Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB 1 receptor antagonist rimonabant in rats

Psychopharmacology

Volumn 216, Issue 3, 2011, Pages 355-365

  Järbe, Torbjörn U C ^a   Lemay, Brian J ^a   Vemuri, V Kiran ^a   Vadivel, Subramanian K ^a   Zvonok, Alexander ^a   Makriyannis, Alexandros ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

AM5983 AM1346 9 THC; Cannabinoid agonists; Cannabinoid antagonists; Drug discrimination; Rats; Rimonabant AM4113 AM6545; Time course

Indexed keywords

AM 1346; AM 4113; AM 5983; AM 6545; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 1 RECEPTOR ANTAGONIST; LITHIUM CHLORIDE; NICOTINE; RIMONABANT; SACCHARIN; SODIUM CHLORIDE; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; AVERSION; COMPARATIVE STUDY; CONTROLLED STUDY; DISCRIMINATION LEARNING; DISCRIMINATIVE STIMULUS; DRINKING BEHAVIOR; DRUG HALF LIFE; IN VIVO STUDY; MALE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; SIGNAL TRANSDUCTION; STIMULUS GENERALIZATION;

ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; LIGANDS; MALE; MORPHOLINES; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; TETRAHYDROCANNABINOL; TIME FACTORS;

EID: 79961172900     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2226-3     Document Type: Article

References (49)

1. CY Baskfield BR Martin JL Wiley 2004 Differential effects of delta-9-tetrahydrocannabinol and methanandamide in CB1 knockout and wild-type mice J Pharmacol Exp Ther 309 86 91 14718593 10.1124/jpet.103.055376 1:CAS:528:DC%2BD2cXivFamt74%3D (Pubitemid 38393118)
2. AP Chambers VK Vemuri Y Peng JT Wood T Olszewska QJ Pittman A Makriyannis KA Sharkey 2007 A neutral CB1 receptor antagonist reduces weight gain in rat Am J Physiol Regul Integr Comp Physiol 293 R2185 R2193 17959701 10.1152/ajpregu.00663.2007 1:CAS:528:DC%2BD2sXhsVOgtbjP (Pubitemid 350224010)
3. NL Cluny VK Vemuri AP Chambers CL Limebeer H Bedard JT Wood B Lutz A Zimmer LA Parker A Makriyannis KA Sharkey 2010 A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents Br J Pharmacol 161 629 642 20880401 10.1111/j.1476-5381.2010.00908.x 1:CAS:528:DC%2BC3cXht1Kju73F
4. C Cohen G Perrault C Voltz R Steinberg P Soubrie 2002 SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats Behav Pharmacol 13 451 463 12394421 10.1097/00008877-200209000-00018 1:CAS:528:DC%2BD38XotFyru70%3D (Pubitemid 35178842)
5. FC Colpaert CJ Niemegeers PA Janssen 1975 Differential response control by isopropamide: a peripherally induced discriminative cue Eur J Pharmacol 34 381 384 11104 10.1016/0014-2999(75)90267-8 1:CAS:528:DyaE28XosVensQ%3D%3D
6. FC Colpaert JJ Kuyps CJ Niemegeers PA Janssen 1976 Discriminative stimulus properties of a low dl-amphetamine dose Arch Int Pharmacodyn Thér 223 34 42 999400 1:CAS:528:DyaE2sXis1SmtA%3D%3D
7. CM Davis GW Stevenson F Canadas T Ullrich KC Rice AL Riley 2009 Discriminative stimulus properties of naloxone in Long-Evans rats: assessment with the conditioned taste aversion baseline of drug discrimination learning Psychopharmacol Berl 203 421 429 10.1007/s00213-008-1233-5 1:CAS:528: DC%2BD1MXivFWgt7k%3D
8. V Di Marzo 2010 Anandamide serves two masters in the brain Nat Neurosci 13 1446 1448 21102567 10.1038/nn1210-1446
9. LO Hanus 2009 Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids Med Res Rev 29 213 271 18777572 10.1002/med.20135 1:CAS:528:DC%2BD1MXjs1Knsb8%3D
10. MA Huestis SJ Boyd SJ Heishman KL Preston D Bonnet G Le Fur DA Gorelick 2007 Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users Psychopharmacol Berl 194 505 515 10.1007/s00213-007-0861-5 1:CAS:528:DC%2BD2sXhtVynur7E (Pubitemid 47492992)
11. DR Janero SK Vadivel A Makriyannis 2009 Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: drug-discovery strategies Int Rev Psychiatry 21 122 133 19367506 10.1080/09540260902782778
12. Järbe TUC (1989) Discrimination learning with drug stimuli: methods and applications. In: Boulten AA, Baker GB, Greenshaw AJ (eds) Neuromethods, vol 13, Psychopharmacology. Humana Press, Clifton, pp 513-563
13. Järbe TUC (2011) Perceptual drug discriminative aspects of the endocannabinoid signaling system in animals and man. In: Glennon RA, Young R (eds) Drug discrimination: applications to medicinal chemistry and drug studies. Wiley Publ. Co., Hoboken
14. TUC Järbe RJ Lamb 1995 Discriminated conditioned taste aversion for studying multi-element stimulus control Behav Pharmacol 6 149 155 11224322
15. TUC Järbe RJ Lamb 1999 Effects of lithium dose (UCS) on the acquisition and extinction of a discriminated morphine aversion: tests with morphine and delta-9-THC Behav Pharmacol 10 349 358 10780803 10.1097/00008877-199907000-00002
16. TUC Järbe R Sheppard RJ Lamb A Makriyannis S Lin A Goutopoulos 1998 Effects of delta-9-tetrahydrocannabinol and (R)-methanandamide on open-field behavior in rats Behav Pharmacol 9 169 174 10065936 (Pubitemid 28186513)
17. 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide Psychopharmacol Berl 156 369 380 10.1007/s002130100730 (Pubitemid 32695845)
18. TUC Järbe ME Andrzejewski NV DiPatrizio 2002 Interactions between the CB1 receptor agonist delta-9-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited Pharmacol Biochem Behav 73 911 919 12213538 10.1016/S0091-3057(02)00938-3 (Pubitemid 35246241)
19. TUC Järbe NV DiPatrizio C Li A Makriyannis 2003 The cannabinoid receptor antagonist SR-141716 does not readily antagonize open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats Pharmacol Biochem Behav 75 809 821 12957223 10.1016/S0091-3057(03)00168-0 (Pubitemid 37289466)
20. TUC Järbe MY Harris C Li Q Liu A Makriyannis 2004 Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB1 receptor antagonist Psychopharmacol Berl 177 35 45 10.1007/s00213-004-1916-5 (Pubitemid 40109912)
21. 9-THC or (R)-methanandamide (AM-356) Psychopharmacol Berl 188 315 323 10.1007/s00213-006-0517-x (Pubitemid 44387459)
22. TUC Järbe Q Liu A Makriyannis 2006 Antagonism of discriminative stimulus effects of delta-9-THC and (R)-methanandamide in rats Psychopharmacol Berl 184 36 45 10.1007/s00213-005-0225-y (Pubitemid 43005755)
23. TUC Järbe NV DiPatrizio C Li A Makriyannis 2007 Effects of AM1346, a high-affinity CB1 receptor selective anandamide analog, on open-field behavior in rats Behav Pharmacol 18 673 680 17912052 10.1097/FBP.0b013e3282f00bbf (Pubitemid 47524894)
24. TUC Järbe BJ LeMay T Olszewska VK Vemuri JT Wood A Makriyannis 2008 Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats Pharmacol Biochem Behav 91 84 90 18640150 10.1016/j.pbb.2008.06.014
25. TUC Järbe C Li SK Vadivel A Makriyannis 2008 Discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats Psychopharmacol Berl 198 467 478 10.1007/s00213-008-1076-0
26. TUC Järbe C Li Q Liu A Makriyannis 2009 Discriminative stimulus functions in rats of AM1346, a high-affinity CB1R selective anandamide analog Psychopharmacol Berl 203 229 239 10.1007/s00213-008-1199-3
27. TUC Järbe RS Gifford A Makriyannis 2010 Antagonism of THC-induced behavioral effects by rimonabant: time course studies in rats Eur J Pharmacol 648 133 138 20854804 10.1016/j.ejphar.2010.09.006
28. Kirk RE (1968) Experimental design: procedures for the behavioral sciences, 2nd edn. Brooks/Cole, Belmont, CA
29. B Le Foll SR Goldberg 2004 Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences NeuroReport 15 2139 2143 15486497 10.1097/00001756-200409150-00028 (Pubitemid 39281762)
30. CL Limebeer VK Vemuri H Bedard ST Lang KP Ossenkopp A Makriyannis LA Parker 2010 Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats Br J Pharmacol 161 336 349 20735419 10.1111/j.1476-5381.2010.00885.x 1:CAS:528:DC%2BC3cXht1KjurjI
31. RS Mansbach CC Rovetti EN Winston JA Lowe 3rd 1996 Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats Psychopharmacol Berl 124 315 322 10.1007/BF02247436 1:CAS:528: DyaK28Xkslyisro%3D (Pubitemid 26149916)
32. PJ McLaughlin K Winston L Swezey A Wisniecki J Aberman DJ Tardif AJ Betz K Ishiwari A Makriyannis JD Salamone 2003 The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats Behav Pharmacol 14 583 588 14665975 10.1097/00008877-200312000-00002 1:CAS:528:DC%2BD3sXps1Kjsrw%3D
33. PJ McLaughlin KM Winston CL Limebeer LA Parker A Makriyannis JD Salamone 2005 The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats Psychopharmacol Berl 180 286 293 10.1007/s00213-005-2171-0 1:CAS:528: DC%2BD2MXltVKntrc%3D (Pubitemid 40909674)
34. 9- tetrahydrocannabinol Psychopharmacol Berl 188 306 314 10.1007/s00213-006-0500-6 1:CAS:528:DC%2BD28XpsFWmt7c%3D (Pubitemid 44387458)
35. 9- tetrahydrocannabinol in C57BL/6J mice Psychopharmacol Berl 198 487 495 10.1007/s00213-007-0900-2 1:CAS:528:DC%2BD1cXmsVegu74%3D (Pubitemid 351754667)
36. LA Parker CL Limebeer EM Rock DL Litt M Kwiatkowska D Piomelli 2009 The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine-induced vomiting in the Suncus murinus (house musk shrew) Physiol Behav 97 121 124 19239915 10.1016/j.physbeh.2009.02.014 1:CAS:528:DC%2BD1MXjslOlt70%3D
37. A Pério M Rinaldi-Carmona J Maruani F Barth G Le Fur P Soubrié 1996 Central mediation of the cannabinoid cue: activity of a selective CB1 antagonist, SR 141716A Behav Pharmacol 7 65 71 11224395 10.1097/00008877-199605001-00188 (Pubitemid 26051785)
38. RG Pertwee 2010 Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists Curr Med Chem 17 1360 1381 20166927 10.2174/092986710790980050 1:CAS:528:DC%2BC3cXmtFehtLs%3D
39. KS Sink PJ McLaughlin JA Wood C Brown P Fan VK Vemuri Y Peng T Olszewska GA Thakur A Makriyannis LA Parker JD Salamone 2008 The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats Neuropsychopharmacology 33 946 955 17581535 10.1038/sj.npp.1301476 1:CAS:528:DC%2BD1cXhvVykt7s%3D (Pubitemid 351252707)
40. KS Sink KN Segovia J Sink PA Randall LE Collins M Correa EJ Markus VK Vemuri A Makriyannis JD Salamone 2009 Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142 Eur Neuropsychopharmacol 20 112 122 20015619 10.1016/j.euroneuro.2009.11.002
41. KS Sink VK Vemuri J Wood A Makriyannis JD Salamone 2009 Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: effects on food-reinforced behavior and comparisons with AM4113 Pharmacol Biochem Behav 91 303 306 18703081 10.1016/j.pbb.2008.07.013 1:CAS:528:DC%2BD1cXhsFansr%2FO
42. KS Sink KN Segovia LE Collins EJ Markus VK Vemuri A Makriyannis JD Salamone 2010 The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats Pharmacol Biochem Behav 95 479 484 20347865 10.1016/j.pbb.2010.03.011 1:CAS:528: DC%2BC3cXlvVGltr4%3D
43. M Solinas LV Panlilio K Antoniou LA Pappas SR Goldberg 2003 The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats J Pharmacol Exp Ther 306 93 102 12660305 10.1124/jpet.102.047928 1:CAS:528:DC%2BD3sXkvF2ltbY%3D (Pubitemid 36734361)
44. M Solinas SR Goldberg D Piomelli 2008 The endocannabinoid system in brain reward processes Br J Pharmacol 154 369 383 18414385 10.1038/bjp.2008.130 1:CAS:528:DC%2BD1cXlvVWgu7w%3D (Pubitemid 351670594)
45. 9-THC in rats: tests with aminoalkylindoles (WIN55,212-2 and AM678) and ethanol. International Cannabinoid Research Society
46. J Tam VK Vemuri J Liu S Batkai B Mukhopadhyay G Godlewski D Osei-Hyiaman S Ohnuma SV Ambudkar J Pickel A Makriyannis G Kunos 2010 Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity J Clin Invest 120 2953 2966 20664173 10.1172/JCI42551 1:CAS:528:DC%2BC3cXhtVaiurzM
47. GA Thakur SP Nikas C Li A Makriyannis 2005 Structural requirements for cannabinoid receptor probes Hand Exp Pharm 168 209 246 10.1007/3-540-26573-2-7 1:CAS:528:DC%2BD2MXkvFeqsL4%3D
48. VK Vemuri DR Janero A Makriyannis 2008 Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome Physiol Behav 93 671 686 18155257 10.1016/j.physbeh.2007.11.012 1:CAS:528:DC%2BD1cXjtlCgs7w%3D (Pubitemid 351410420)
49. H Welzl P D'Adamo HP Lipp 2001 Conditioned taste aversion as a learning and memory paradigm Behav Brain Res 125 205 213 11682112 10.1016/S0166-4328(01) 00302-3 1:STN:280:DC%2BD3MrnsVGjsA%3D%3D (Pubitemid 33000459)